Trial · NCT07883525
A Clinical Study to Evaluate the Effects of a Supplement on Cognitive Function
NCT07883525, Not applicable, Active not recruiting, Necternal LLC
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Clinical Study to Evaluate the Effects of a Supplement on Cognitive Function. Trials, record NCT07883525. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883525
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Clinical Study to Evaluate the Effects of a Supplement on Cognitive Function
- NCT number
- NCT07883525
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 128 participants, actual
- Lead sponsor
- Necternal LLC
- Conditions
- Cognition Improvement, Cognition Function
- Interventions
- Necternal Supplement, Placebo
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Cognitive Function as Assessed by Polygons | Baseline, 4 weeks, 8 weeks, and 16 weeks | Mean change from baseline in the Polygons test score, assessing processing speed and judgment. Participants will complete a timed, computerized cognitive assessment with a duration of 1 minute and 30 seconds. The outcome will be calculated as the mean change in test score from baseline at each follow-up assessment. |
| Primary | Change in Cognitive Function as Assessed by Double Trouble | Baseline, Week 4, Week 8, and Week 16 | Mean change from baseline in the Double Trouble test score, assessing selective attention and processing speed. Participants will complete a timed, computerized Stroop-based cognitive assessment with a duration of 1 minute and 30 seconds. The outcome will be calculated as the mean change in test score from baseline at each follow-up assessment. |
| Primary | Change in Cognitive Function as Assessed by Feature Match | Baseline, Week 4, Week 8, and Week 16 | Mean change from baseline in the Feature Match test score, assessing focus and processing. Participants will complete a timed, computerized cognitive assessment with a duration of 1 minute and 30 seconds. The outcome will be calculated as the mean change in test score from baseline at each follow-up assessment. |
| Secondary | Change in Self-Reported Mental Acuity | Baseline, Week 2, Week 6, Week 12, and Week 16 | Mean change from baseline in participants' self-reported mental acuity, assessed using a questionnaire. The outcome will be calculated as the mean change in the mental acuity score from baseline at each follow-up assessment. Higher or lower scores will be interpreted according to the scoring instructions of the questionnaire. |
| Secondary | Change in Self-Reported Memory | Baseline, Week 2, Week 6, Week 12, and Week 16 | Mean change from baseline in participants' self-reported memory, assessed using a questionnaire. The outcome will be calculated as the mean change in the memory score from baseline at each follow-up assessment. Higher or lower scores will be interpreted according to the scoring instructions of the questionnaire. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883525
GET https://conductscience.org/api/trials/v1/NCT07883525/registered